.Novartis levels a brand new frontier in its own cooperation with Voyager Therapies, paying $15 thou...
.On the heels of an FDA turndown for its chief rival Novo Nordisk, Eli Lilly is making headway in th...
.Simply a few months after application the initial individual in a stage 2 test for recently detecte...
.Eli Lilly's look for excessive weight intendeds has actually led it to the dark genome. The Big Pha...
.Toolbox Biosciences is proceeding up. The cell treatment company has added on $325 million in ammun...
.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has actually s...
.Aelis Farma's chances of getting an easy, beneficial decision on a $one hundred thousand option pay...
.ProKidney has actually quit some of a set of phase 3 trials for its own tissue therapy for renal he...
.Vaxcyte introduced what professionals referred to as "spectacular" stage 1/2 data for its own 31-va...
.Recursion has actually stumbled with a very early exam of its tech-enabled method to medicine revel...